| Variable | HIV DNA Positive (%) | HIV DNA Negative (%) | Total (%) | X2 | P = value |
| Ages of infants at DBS Sample collection |
|
| |||
| <6 weeks | 58 (2.3) | 2456 (97.7) | 2514 (25.6) | 38.865 | 0.001 |
| >6 - 8 weeks | 69 (1.7) | 4008 (93.3) | 4077 (41.5) |
|
|
| >8 - 12 weeks | 19 (3.3) | 551 (96.6) | 570 (5.8) |
|
|
| >12 weeks | 109 (4.1) | 2553 (95.9) | 2662 (27.1) |
|
|
| Sex |
|
|
| ||
| Male | 143 (2.9) | 4794 (97.1) | 4937 (50.2) | 76.055 | 0.001 |
| Female | 112 (2.3) | 4774 (97.7) | 4886 (49.8) |
|
|
| Cotrimoxazole prophylaxis given to infant |
|
| |||
| No Cotrimoxazole | 51 (3.7) | 1334 (96.3) | 1385 (14.1) | 7.696 | 0.006 |
| Yes, receiving cotrimoxazole daily | 204 (2.4) | 8234 (97.6) | 8438 (85.9) |
|
|
| Breastfeeding status at the time of DBS sample collection |
|
| |||
| Yes, breastfeeding | 214 (2.5) | 8342 (97.5) | 8556 (87.1) | 1.095 | 0.295 |
| Not breastfeeding | 41 (3.2) | 1226 (96.8) | 1267 (12.9) |
|
|
| Was HIV-exposed infant ever breastfed? |
|
| |||
| Yes | 246 (2.6) | 9223 (97.4) | 9469 (96.4) | 0.348 | 0.556 |
| No | 9 (2.5) | 345 (97.5) | 354 (3.6) |
|
|